相关实验视频
Updated: Sep 11, 2025
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
28.1K
症状性心肌桥:长期结果和策略
Mingkui Zhang1, Qingyu Wu1, Zhengjie Zhang1
1The First Hospital of Tsinghua University, Tsinghua University, Beijing, China.
The Journal of thoracic and cardiovascular surgery
|August 16, 2025
概括
对于心肌桥梁 (MB) 建议进行手术骨髓切割,严重的压缩对药物无反应. 结合手术是有效的MB与其他心脏病,而医学治疗适合轻度病例.
科学领域:
- 心脏病学 心脏病学
- 遗传性心脏病是一种先天性心脏病.
- 心脏外科手术 心脏外科手术
背景情况:
- 心肌桥梁 (MB) 是一种先天性冠状动脉异常.
- 对于MB的治疗策略,特别是与其他心脏疾病相结合时,仍然存在争议.
- 了解不同MB严重程度和治疗方式的结果至关重要.
研究的目的:
- 为了比较心肌桥的手术与医疗治疗结果.
- 评估 MB 严重程度 (心缩压缩<70% vs. ≥70%) 对治疗疗效的影响.
- 评估孤立心脏病患者与同时存在心脏病患者的结局.
主要方法:
- 通过冠状动脉血管学诊断的243名心肌桥梁患者的回顾性分析.
- 患者被分为手术 (A组:n=77) 和医疗 (B组:n=166) 的治疗组.
- 分组根据压缩严重程度 (≥70% vs <70%) 和其他心脏手术的存在来定义.
主要成果:
- 所有组的10年生存率都很高 (88.2%-95%).
- 在手术组 (85.0%-89.7%) 与医疗组 (67.8%-74.4%) 相比,无重大心脏不良事件 (MACE) 显着更高,特别是在严重的MB.
- 手术骨髓切割显示,单独的MB与严重的压缩耐药的医疗治疗的结果更好.
结论:
- 肌切除术优于医疗治疗,用于孤立的心肌桥梁,严重的缩压缩对药物无反应.
- 结合肌切除术和心脏手术,对与其他心脏疾病并存的肌心桥产生了令人满意的结果.
- 医疗治疗对具有孤立心肌桥梁和轻度缩压缩 (<70%) 的症状患者有效.
相关概念视频
01:22Myocarditis IV: Nursing Management
26
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
26
01:29Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
01:14Myocarditis III: Medical Management
16
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16
01:26Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
01:30Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22